BWXT vs. MRK
BWXT (BWX Technologies, Inc.) and MRK (Merck & Co., Inc.) are both stocks. BWXT operates in Aerospace & Defense (Industrials), while MRK operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, BWXT returned 19.48%/yr vs 11.61%/yr for MRK. At a 0.21 correlation, their price movements are largely independent.
Performance
BWXT vs. MRK - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BWXT achieves a 8.75% return, which is significantly lower than MRK's 14.39% return. Over the past 10 years, BWXT has outperformed MRK with an annualized return of 19.48%, while MRK has yielded a comparatively lower 11.61% annualized return.
BWXT
- 1D
- 0.81%
- 1M
- -8.58%
- YTD
- 8.75%
- 6M
- 5.16%
- 1Y
- 45.32%
- 3Y*
- 43.65%
- 5Y*
- 25.34%
- 10Y*
- 19.48%
MRK
- 1D
- -1.05%
- 1M
- 7.31%
- YTD
- 14.39%
- 6M
- 22.75%
- 1Y
- 56.85%
- 3Y*
- 5.78%
- 5Y*
- 13.57%
- 10Y*
- 11.61%
BWXT vs. MRK - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BWXT BWX Technologies, Inc. | 8.75% | 56.37% | 46.53% | 33.87% | 23.30% | -19.40% | -1.54% | 64.48% | -36.10% | 53.59% |
MRK Merck & Co., Inc. | 14.39% | 9.79% | -6.26% | 1.01% | 49.42% | 1.75% | -7.20% | 22.27% | 39.95% | -1.49% |
Correlation
The correlation between BWXT and MRK is 0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.02 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.01 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.07 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Aug 2, 2010 | 0.21 |
The correlation between BWXT and MRK shifts across timeframes, from 0.01 (3 years) to 0.21 (all time), reflecting how their relationship changes across market environments.
Fundamentals
BWXT:
$17.23B
MRK:
$295.45B
BWXT:
$3.75
MRK:
$3.58
BWXT:
49.94
MRK:
33.34
BWXT:
13.20
MRK:
0.03
BWXT:
5.10
MRK:
4.54
BWXT:
13.46
MRK:
6.44
BWXT:
$3.38B
MRK:
$65.59B
BWXT:
$566.27M
MRK:
$49.79B
BWXT:
$534.48M
MRK:
$22.69B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BWXT vs. MRK — Risk / Return Rank
BWXT
MRK
BWXT vs. MRK - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for BWX Technologies, Inc. (BWXT) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BWXT | MRK | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.08 | ||
| Sortino ratioReturn per unit of downside risk | -1.44 | ||
| Omega ratioGain probability vs. loss probability | 1.21 | 1.36 | -0.15 |
| Calmar ratioReturn relative to maximum drawdown | 2.03 | 5.03 | -3.00 |
| Martin ratioReturn relative to average drawdown | 4.59 | 12.59 | -8.00 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BWXT | MRK | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.02 | 2.10 | -1.08 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.77 | 0.58 | +0.20 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.64 | 0.51 | +0.13 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.60 | 0.48 | +0.12 |
Drawdowns
BWXT vs. MRK - Drawdown Comparison
The maximum BWXT drawdown since its inception was -47.88%, smaller than the maximum MRK drawdown of -68.61%. Use the drawdown chart below to compare losses from any high point for BWXT and MRK.
Loading charts...
Drawdown Indicators
| BWXT | MRK | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -47.88% | -68.61% | +20.73% |
Max Drawdown (1Y)Largest decline over 1 year | -22.42% | -11.37% | -11.05% |
Max Drawdown (3Y)Largest decline over 3 years | -32.87% | -43.44% | +10.57% |
Max Drawdown (5Y)Largest decline over 5 years | -32.92% | -43.44% | +10.52% |
Max Drawdown (10Y)Largest decline over 10 years | -47.74% | -43.44% | -4.30% |
Current DrawdownCurrent decline from peak | -21.27% | -4.65% | -16.62% |
Average DrawdownAverage peak-to-trough decline | -13.17% | -18.84% | +5.67% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.89% | 4.53% | +5.36% |
Volatility
BWXT vs. MRK - Volatility Comparison
BWX Technologies, Inc. (BWXT) and Merck & Co., Inc. (MRK) have volatilities of 9.26% and 9.44%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BWXT | MRK | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.26% | 9.44% | -0.18% |
Volatility (6M)Calculated over the trailing 6-month period | 33.52% | 18.14% | +15.38% |
Volatility (1Y)Calculated over the trailing 1-year period | 44.79% | 27.30% | +17.49% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 32.91% | 23.71% | +9.20% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 30.77% | 22.96% | +7.81% |
Dividends
BWXT vs. MRK - Dividend Comparison
BWXT's dividend yield for the trailing twelve months is around 0.55%, less than MRK's 2.78% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BWXT BWX Technologies, Inc. | 0.55% | 0.58% | 0.86% | 1.20% | 1.52% | 1.75% | 1.26% | 1.10% | 1.67% | 0.69% | 0.91% | 30.37% |
MRK Merck & Co., Inc. | 2.78% | 3.12% | 3.14% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.43% |
Financials
BWXT vs. MRK - Financials Comparison
This section allows you to compare key financial metrics between BWX Technologies, Inc. and Merck & Co., Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BWXT vs. MRK - Profitability Comparison
BWXT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, BWX Technologies, Inc. reported a gross profit of 0.00 and revenue of 860.22M. Therefore, the gross margin over that period was 0.0%.
MRK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported a gross profit of 13.34B and revenue of 16.29B. Therefore, the gross margin over that period was 81.9%.
BWXT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, BWX Technologies, Inc. reported an operating income of 106.69M and revenue of 860.22M, resulting in an operating margin of 12.4%.
MRK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported an operating income of -1.88B and revenue of 16.29B, resulting in an operating margin of -11.6%.
BWXT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, BWX Technologies, Inc. reported a net income of 91.19M and revenue of 860.22M, resulting in a net margin of 10.6%.
MRK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported a net income of -4.24B and revenue of 16.29B, resulting in a net margin of -26.0%.
Frequently Asked Questions
BWXT and MRK have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MRK has higher volatility (9.44%) compared to BWXT (9.26%). In terms of maximum drawdown, BWXT dropped -47.88% vs MRK's -68.61%.
MRK currently has the higher Sharpe Ratio (2.10 vs 1.02), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BWXT and MRK
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer